Evaluation of the Effectiveness of a City Hospital Care Network for the Care of Patients With Transient Ischemic Accident (TIA) (AIT-AMBU-GRE)

Transient ischemic accidents (TIA) are a frequent resort to hospitalization in the emergency department and are serious events in terms of recurrence and handicap. The organization of the "TIA sector" at CHUGA aims to facilitate on the one hand the care of the patient during his hospitalization in the emergencies and on the other hand to allow a safer discharge of the patient as well as his follow-up in ambulatory. The aim of this study is to study the feasibility of comprehensive short-term outpatient management after hospitalization in the emergencies. The research hypothesis is that 90% of patients complete all of the 10 recommended examinations for the diagnosis of TIA, analysis of its risk factors and initiation of necessary treatments, if necessary.

Study Overview

• Status: Recruiting
• Conditions: Transient Ischemic Attack
• Intervention / Treatment: Other: Check of the different exams performed at the emergencies

Detailed Description

Current knowledge on pathology Transient ischemic accidents (TIA) are a frequent resort to hospitalization in the emergency department (378 visits in 2019 to the CHUGA emergencies, 340 in 2020, or about 1 entry for this reason per day) and are serious events in terms of recurrence and handicap. The risk of Cerebral Vascular Accident (stroke) is around 10% at 3 months after the first episode of TIA [1]. Standardizing care and improving patient compliance with treatment and monitoring of their pathology aims to reduce the recurrence and the occurrence of more serious consequences.

In 2021, the Northern Alpine Emergency Network (RENAU) published standardized care for all hospitals and clinics dependent on this network, based on the French recommendations of the Haute Autorité de Santé and the French Neurovascular Society (SFNV).

This care was put in place at the Emergency Department of the CHU Grenoble Alpes (CHUGA) in the form of an "TIA program" and defines the patient's journey when he presents signs compatible with the suspicion of TIA. In addition to being based on national and regional recommendations, this sector has been improved by providing a questionnaire to all Neuro-Vascular Units (NVU) in France.

The organization of the "TIA sector" at CHUGA aims to facilitate on the one hand the care of the patient during his hospitalization in the emergency room and on the other hand to allow a safer discharge of the patient as well as his follow-up in ambulatory.

For example, a Parisian study, carried out at the Bichat hospital [2], showed that a standardized treatment pathway for TIAs was linked to a reduction of more than 30% in the risk of stroke 3 months after the TIA.

On arrival at the Emergency Department, in the event of any suggestive signs, the patient is included in the "TIA sector". He is examined as quickly as possible by an emergency physician and / or the neurologist on call. A predefined biology is taken and an electrocardiogram (ECG) is performed.

The patient undergoes a brain imaging test. Depending on availability, two imaging modalities are possible: brain CT-scan without injection followed by Doppler ultrasound of the supra-aortic trunks during the week during working hours, or a CT angiography with visualization of the supra-aortic trunks at night, on weekends and on holidays. Finally, the patient benefits from close monitoring. Depending on the clinical evaluation and the examinations carried out, the neurologist based in the Emergency Department, in agreement with the emergency physician, decides on the continuation of the treatment (hospitalization / come back home, drug treatment).

The criteria for hospitalization are generally represented by the discovery of a cardiac arrhythmia, an abnormality in the brain imaging or supra-aortic trunks, repeated TIAs, a significant duration of symptoms or a history and important cardiovascular risk factors.

If the patient does not present criteria for hospitalization, a return home is offered. For 56% of patients at the CHUGA in 2019 and 62% in 2020, outpatient care was decided. These are the patients that interest us in this study. When discharging from the emergency room, the "outpatient" treatment route is relatively heavy. Treatment will eventually be initiated and the patient will have outpatient examinations as well as schedule several consultations.

The patient must in particular schedule a consultation with a cardiologist (to perform a Holter ECG and a cardiac ultrasound), carry out several additional examinations including a brain MRI and laboratory tests and schedule a follow-up with a neurologist and his attending physician. .

The aim of this study is to study the feasibility of comprehensive short-term outpatient management after hospitalization in the emergencies. We want to assess the proper performance of all the examinations prescribed from the Emergency Department, the taking of the prescribed treatment, the patient's understanding of his pathology and his feelings about his care.

Patient management is not affected by this study.

Depending on the results, we will be able to target if certain elements are not feasible and thus improve the sector or even distribute it to other centers, in particular via the RENAU.

It is a single-center prospective descriptive epidemiological study conducted at the CHUGA within the Emergency Department.

Research hypotheses and expected results The research hypothesis is that 90% of patients complete all of the 10 recommended examinations for the diagnosis of TIA, analysis of its risk factors and initiation of necessary treatments, if necessary.

This percentage is arbitrary because no such study on the subject has yet been published. This high rate seems relevant to us to reflect the proper functioning of the sector.

• Study Type: Observational
• Enrollment (Anticipated): 51

Contacts and Locations

Study Locations

• France
  • Grenoble, France, 38100
    • Recruiting
    • CHU Grenoble Alpes - Urgences
    • Contact: Vivien Brenckmann, Dr; Phone Number: 0476767575; Email: vbrenckmann@chu-grenoble.fr

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: N/A
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Diagnostic of TIA by the exams performed in the emergencies of CHUGA.

Description

Inclusion Criteria:

• Hospitalization in the Emergency Department of the CHUGA for suspicion of TIA
• Possible or probable TIA diagnosis on discharge
• Major patient
• Outpatient care after emergency care

Exclusion Criteria:

• Protected patient (guardianship, curatorship, people not affiliated with Social Security)
• Patient deprived of liberty by a judicial or administrative decision
• Patient hospitalized without consent under Articles L. 3212-1 and L. 3213-1 which does not fall under the provisions of Article L. 1121-8
• Adult patient subject to a legal protection measure or unable to express consent
• Pregnant, lactating or parturient women
• Patient who does not speak French
• Inability to answer the phone to answer questions
• No attending physician

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
TIA patients; Diagnostic of TIA by the exams performed in the emergencies of CHUGA.	Other: Check of the different exams performed at the emergencies; Check of the different exams performed at the emergencies

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The objective of the research is to study the feasibility of outpatient treatment for TIA from the emergency room, by evaluating the percentage of patients who have completed 100% of the additional examinations included in the course.	The primary endpoint is the mandatory completion of the 10 items recommended by the SFNV and the RENAU, as part of the diagnosis and management of TIA: Recommended standard biology (including assessment of cardiovascular risk factors); The electrocardiogram; Brain imaging; Imaging of the supraortic trunks; The summary of all examinations by a neurologist; The introduction of antiplatelet therapy; The introduction of statins; The follow-up consultation with the attending physician in the month following discharge from the emergency room.; Consultation with a cardiologist, with performance of an echocardiography and a Holter ECG; Performing a brain MRI	6 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Identify the additional examinations that are not performed during the patient's care, and the difficulties in carrying out the standardized care offered to the Emergency Department	Collection of examinations not performed during patient care	6 months
Evaluate the patient's adherence and understanding to the care sector	Assessment of the patient's adherence to and understanding of the sector, based on a score on 8 questions rated from 0 to 5 Use of the score in questions V of the questionnaire to assess the patient's feelings	6 months
Identify the barriers to membership in the care sector	Collection and interpretation of examinations not performed during patient care	6 months
Identify complications at one month including a recurrence of TIA or stroke	Occurrence of a complication at one month (TIA or stroke) on the declarative basis, by the patient, during the telephone call one month after discharge from the Emergency Department	6 months

Collaborators and Investigators

• Sponsor: University Hospital, Grenoble

Publications and helpful links

General Publications

• Lavallee PC, Meseguer E, Abboud H, Cabrejo L, Olivot JM, Simon O, Mazighi M, Nifle C, Niclot P, Lapergue B, Klein IF, Brochet E, Steg PG, Leseche G, Labreuche J, Touboul PJ, Amarenco P. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol. 2007 Nov;6(11):953-60. doi: 10.1016/S1474-4422(07)70248-X.
• Amarenco P, Benavente O. EXPRESS transient ischemic attack study: speed the process! Stroke. 2008 Aug;39(8):2400-1. doi: 10.1161/STROKEAHA.108.514166. Epub 2008 Jul 3. No abstract available.
• Amarenco P. Not all patients should be admitted to the hospital for observation after a transient ischemic attack. Stroke. 2012 May;43(5):1448-9. doi: 10.1161/STROKEAHA.111.636753. No abstract available.
• Amarenco P, Lavallee PC, Monteiro Tavares L, Labreuche J, Albers GW, Abboud H, Anticoli S, Audebert H, Bornstein NM, Caplan LR, Correia M, Donnan GA, Ferro JM, Gongora-Rivera F, Heide W, Hennerici MG, Kelly PJ, Kral M, Lin HF, Molina C, Park JM, Purroy F, Rothwell PM, Segura T, Skoloudik D, Steg PG, Touboul PJ, Uchiyama S, Vicaut E, Wang Y, Wong LKS; TIAregistry.org Investigators. Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke. N Engl J Med. 2018 Jun 7;378(23):2182-2190. doi: 10.1056/NEJMoa1802712. Epub 2018 May 16.
• Cucchiara BL, Kasner SE. All patients should be admitted to the hospital after a transient ischemic attack. Stroke. 2012 May;43(5):1446-7. doi: 10.1161/STROKEAHA.111.636746. No abstract available.

Study record dates

Study Major Dates

• Study Start (Actual): April 7, 2022
• Primary Completion (Anticipated): June 1, 2022
• Study Completion (Anticipated): July 1, 2022

Study Registration Dates

• First Submitted: January 11, 2022
• First Submitted That Met QC Criteria: January 17, 2022
• First Posted (Actual): January 31, 2022

Study Record Updates

• Last Update Posted (Actual): May 24, 2022
• Last Update Submitted That Met QC Criteria: May 17, 2022
• Last Verified: January 1, 2022

More Information

Terms related to this study

• Keywords: transient ischemic attack; neurovascular unit; managed care program
• Additional Relevant MeSH Terms: Pathologic Processes; Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Brain Ischemia; Ischemia; Ischemic Attack, Transient
• Other Study ID Numbers: EssaiClinique_AIT-AMBU-GRE

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No